Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-100
Closed -$11.4K 406
2025
Q4
$11.4K Hold
100
﹤0.01% 283
2025
Q3
$13.3K Hold
100
﹤0.01% 248
2025
Q2
$14.2K Hold
100
﹤0.01% 240
2025
Q1
$15.3K Hold
100
﹤0.01% 254
2024
Q4
$15K Hold
100
﹤0.01% 248
2024
Q3
$16.4K Hold
100
﹤0.01% 282
2024
Q2
$13.9K Hold
100
﹤0.01% 277
2024
Q1
$13.8K Hold
100
﹤0.01% 253
2023
Q4
$10.5K Hold
100
﹤0.01% 265
2023
Q3
$9.45K Hold
100
﹤0.01% 254
2023
Q2
$10K Hold
100
﹤0.01% 273
2023
Q1
$8.11K Buy
+100
New +$8.01K ﹤0.01% 254
2022
Q3
Sell
-100
Closed -$8K 111
2022
Q2
$8K Buy
+100
New +$10.1K ﹤0.01% 75
2021
Q4
Sell
-100
Closed -$12K 108
2021
Q3
$12K Buy
+100
New +$12.5K 0.01% 69

Other funds holding DVA

Godsey & Gibb Inc's DVA Position: Q1 2026 in Review

Godsey & Gibb Inc sold out of DaVita (DVA) in Q1 2026, closing a stake of 100 shares — an estimated $11.4K sold.

Godsey & Gibb Inc first reported a position in DVA in Q3 2021 and held it in 14 quarters. The position peaked at $16.4K in Q3 2024. 583 funds tracked by Wall St. Rank hold DVA as of Q1 2026.

  • Godsey & Gibb Inc reported no remaining DaVita position as of Q1 2026 after selling out during the quarter.
  • Godsey & Gibb Inc sold 100 DaVita shares in Q1 2026, an estimated $11.4K.
  • Godsey & Gibb Inc first reported a position in DaVita in Q3 2021 and held it in 14 quarters.
  • Godsey & Gibb Inc's DaVita position peaked at $16.4K in Q3 2024.
  • 583 funds tracked by Wall St. Rank held DaVita as of Q1 2026.

Based on Godsey & Gibb Inc's 13F filing for Q1 2026, filed 20 Apr 2026.